勘误：每日一次或两次给予兔比马前列素眼用溶液的眼药代动力学和耐受性及临床给药意义[勘误]
Erratum: Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum].
出版信息
Clin Ophthalmol. 2018 Aug 17;12:1471. doi: 10.2147/OPTH.S179994. eCollection 2018.
Abstract
[This corrects the article on p. 1761 in vol. 11, PMID: 29026287.].
摘要
[这纠正了第11卷第1761页上的文章， PMID: 29026287。]
相似文献
1
Erratum: Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum].勘误：每日一次或两次给予兔比马前列素眼用溶液的眼药代动力学和耐受性及临床给药意义[勘误]
Clin Ophthalmol. 2018 Aug 17;12:1471. doi: 10.2147/OPTH.S179994. eCollection 2018.
2
Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications.每日一次或两次给予兔子比马前列素滴眼液的眼药代动力学和耐受性以及临床给药意义。
Clin Ophthalmol. 2017 Sep 28;11:1761-1767. doi: 10.2147/OPTH.S143428. eCollection 2017.
3
Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.眼压升高患者中一日一次或一日两次使用比马前列素与一日两次使用噻吗洛尔的比较：一项为期3个月的临床试验。
Ophthalmology. 2001 Jun;108(6):1023-31; discussion 1032. doi: 10.1016/s0161-6420(01)00584-x.
4
Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.局部用比马前列素：其在开角型青光眼和高眼压症中应用的综述
Drugs Aging. 2002;19(3):231-48. doi: 10.2165/00002512-200219030-00008.
5
A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.一项比较比马前列素和噻吗洛尔治疗青光眼和高眼压症的随机、双盲、多中心临床试验。
Br J Ophthalmol. 2003 Jan;87(1):57-62. doi: 10.1136/bjo.87.1.57.
6
Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.比马前列素降低青光眼和高眼压症患者眼压的长期疗效及安全性：第4年
Br J Ophthalmol. 2008 Oct;92(10):1387-92. doi: 10.1136/bjo.2007.128454. Epub 2008 Jul 11.
7
Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.眼压升高患者中，比马前列素每日一次和每日两次与噻吗洛尔每日两次的六个月比较。
Surv Ophthalmol. 2001 May;45 Suppl 4:S361-8. doi: 10.1016/s0039-6257(01)00219-3.
8
Corrigendum.勘误
Paediatr Child Health. 2015 Nov-Dec;20(8):466-7. doi: 10.1093/pch/20.8.466.
9
Erratum: Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum].勘误：在一项III期随机对照试验OPUS-3中对5.0%的lifitegrast眼用溶液进行的眼部舒适度评估[勘误]
Clin Ophthalmol. 2018 May 17;12:913. doi: 10.2147/OPTH.S168970. eCollection 2018.
10
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.比马前列素/噻吗洛尔固定组合与多佐胺/溴莫尼定/噻吗洛尔固定组合治疗原发性开角型青光眼或高眼压症患者的疗效和耐受性：一项多中心、前瞻性、交叉研究。
BMC Ophthalmol. 2014 Dec 19;14:161. doi: 10.1186/1471-2415-14-161.
Zotero 插件